Table 1 Patients characteristics in the Cancer Genome Atlas.
Variables | Total (n = 86) | High (n = 48) | Low (n = 38) | P |
|---|---|---|---|---|
Age, n (%) | 0.184 | |||
≤60 | 44 (51.16) | 21 (43.75) | 23 (60.53) | |
≥61 | 42 (48.84) | 27 (56.25) | 15 (39.47) | |
Gender, n (%) | 0.45 | |||
Female | 39 (45.35) | 24 (50) | 15 (39.47) | |
Male | 47 (54.65) | 24 (50) | 23 (60.53) | |
Group, n (%) | 0.005 | |||
histoGBM | 71 (82.56) | 45 (93.75) | 26 (68.42) | |
molGBM | 15 (17.44) | 3 (6.25) | 12 (31.58) | |
KPS, n (%) | 0.228 | |||
≤80 | 21 (24.42) | 14 (29.17) | 7 (18.42) | |
>80 | 50 (58.14) | 24 (50) | 26 (68.42) | |
Unknown | 15 (17.44) | 10 (20.83) | 5 (13.16) | |
Chemotherapy, n (%) | 0.037 | |||
NO | 2 (2.33) | 2 (4.17) | 0 (0) | |
Unknown | 20 (23.26) | 15 (31.25) | 5 (13.16) | |
YES | 64 (74.42) | 31 (64.58) | 33 (86.84) | |
Radiation, n (%) | 0.005 | |||
NO | 10 (11.63) | 10 (20.83) | 0 (0) | |
Unknown | 9 (10.47) | 4 (8.33) | 5 (13.16) | |
YES | 67 (77.91) | 34 (70.83) | 33 (86.84) | |
MGMT_promoter, n (%) | 0.452 | |||
Methylated | 26 (30.23) | 17 (35.42) | 9 (23.68) | |
Unknown | 17 (19.77) | 8 (16.67) | 9 (23.68) | |
Unmethylated | 43 (50) | 23 (47.92) | 20 (52.63) |
